by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Tentamus India Private Limited Warning Letter Details

Warning Letter

Tentamus India Private Limited

Tentamus India Private Limited, 3-31/33, Part Sy. No. 123, 124, 125 & 142, Kompally Quthbullapur Hyderabad 500014 Telangana India

Issue DateMarch 03, 2026

FEI Number3010960741

Violations3

CountryIndia

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Tentamus India Private Limited FDA Warning Letter, March 3, 2026